Patent: 10,221,140
✉ Email this page to a colleague
Summary for Patent: 10,221,140
Title: | Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy |
Abstract: | The invention provides novel asymmetric and symmetric bisaminoquinolmes and related compounds, methods of treatment and syntheses. The novel compounds exhibit effective anticancer activity and are useful in the treatment of a variety of autophagy-related disorders. |
Inventor(s): | Amaravadi; Ravi K. (Media, PA), Winkler; Jeffrey (Wynnewood, PA) |
Assignee: | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (Philadelphia, PA) |
Application Number: | 15/502,330 |
Patent Claims: | see list of patent claims |
Details for Patent 10,221,140
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Recordati Rare Diseases, Inc. | ELSPAR | asparaginase | For Injection | 101063 | 01/10/1978 | ⤷ Try a Trial | 2034-08-08 |
Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | 06/21/1989 | ⤷ Try a Trial | 2034-08-08 |
Merck Teknika Llc | N/A | bcg vaccine | For Injection | 103050 | 06/21/1989 | ⤷ Try a Trial | 2034-08-08 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |